15
Participants
Start Date
June 9, 2022
Primary Completion Date
November 14, 2023
Study Completion Date
February 6, 2024
Niraparib
The starting dose will be 300 mg niraparib (or modified according patient weight and platelet count), taken orally once a day for each cycle of 28 days.
Stephenson Cancer Center, Oklahoma City
Collaborators (1)
GlaxoSmithKline
INDUSTRY
University of Oklahoma
OTHER